Avidhrt

Avidhrt has developed the Avidhrt Sense device—a handheld clinical-grade monitor that combines electrocardiogram (ECG), pulse oximetry (SpO2), and infrared body temperature measurement. The system includes a HIPAA-compliant mobile app/dashboard for real-time recording, anomaly detection via machine learning algorithms, secure data storage/sharing with clinicians, and remote patient management. The technology is designed to improve early detection of atrial fibrillation and other arrhythmias to reduce stroke risk and cardiac morbidity/mortality. No published clinical trial results are referenced; performance claims focus on accuracy compared to standard office-based diagnostics.